Study Details
Full Title
A Phase 1b, Open-Label, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma
Principal Investigator
Cristina
Gasparetto
Protocol Number
PRO00119697
NCT ID
NCT07280013
Phase
I
Enrollment Status
Open to Enrollment